| Financial Year |
March 31 2023 |
| Monetary Funds |
2,066,197,707.34 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
259,109,595.63 |
| Accounts Receivable |
2,174,193,806.72 |
| Advances to Suppliers |
58,679,276.19 |
| Other Receivables |
19,588,302.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
5,960,100.00 |
| Dividend Receivable |
-- |
| Inventories |
764,073,150.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
164,388.89 |
| Other Current Assets |
6,160,655.76 |
| Total Current Assets |
5,364,200,534.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
5,145,815.20 |
| Fixed Assetes |
701,396,052.59 |
| Under-construction Projects |
68,733,565.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
134,855,695.24 |
| R&D expenses |
-- |
| Goodwill |
60,249,485.50 |
| Long-Term Deferred and Prepaid Expenses |
114,529.05 |
| Deferred Income Tax Assets |
77,312,504.20 |
| Other Non-Current Assets |
45,541,241.72 |
| Sub-Total of Non-Current Assets |
1,101,914,688.11 |
| Total Assets |
6,466,115,222.46 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
592,271,549.84 |
| Accounts Payable |
2,179,413,798.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
43,204,384.78 |
| Taxes Payable |
53,757,581.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
94,382,339.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,541,552.09 |
| Other Current Liabilities |
65,067.88 |
| Sub-Total of Current Liabilities |
3,104,676,287.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
7,933,184.43 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,901,371.79 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,419,961.33 |
| Total Liabilities |
3,124,096,248.98 |
| Paid-In Capital(Or Share Stock) |
1,497,663,566.00 |
| Capital Surplus |
183,237,418.37 |
| Surplus Reserve |
112,400,469.56 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
770,373,879.64 |
| Minority Stockholder's Interest |
756,122,361.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,585,896,611.77 |
| Owner's Equity（Stockholder's Equity） |
3,342,018,973.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,466,115,222.46 |
